Kingsley Essien

Kingsley Essien is an Instructor in the Department of Dermatology at the University of Massachusetts Chan Medical School. His research focuses on the immunopathogenesis of vitiligo, with a particular emphasis on chemokine networks, regulatory T cells, and translational therapies. He holds a PhD in Biomedical Sciences from the University of Massachusetts Medical School and a BS in Biology from Providence College.

Dr. Essien's work explores mechanisms underlying autoimmune skin diseases, including the role of T-cell positioning mediated by chemokines (e.g., CCR6 and CCR5). He has contributed to studies demonstrating the therapeutic potential of simvastatin in vitiligo and identified biomarkers derived from keratinocyte-derived chemokines. His collaborative network includes prominent immunologists like Prof. John E. Harris.

• Education:
  • BS Biology, Providence College
  • PhD Biomedical Sciences, University of Massachusetts Medical School

His publications span Journal of Investigative Dermatology, Science Translational Medicine, and Proceedings of the National Academy of Sciences, reflecting contributions to both dermatological and broader immunological research. His work has been cited over 300 times and highlighted in news outlets and social media platforms.